Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06564662 · ClinicalTrials.gov registry record
Rapid-Response EEG in Children With Suspected Status Epilepticus
A clinical trial of Status Epilepticus and Coma, sponsored by Children's Hospital at Montefiore.
- Recruiting
- Registry status
- 60
- Enrollment target
- 1
- Study location
NCT06564662 is a study of Status Epilepticus and Coma that is actively recruiting participants, run by Children's Hospital at Montefiore. The registered enrollment target is 60 participants, below the 2,827-participant average among 10 other Status Epilepticus trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06564662, a study of Status Epilepticus and Coma, is actively recruiting participants, sponsored by Children's Hospital at Montefiore.
- RECRUITING
- Registry status
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
Seizures are common in children (\~350 per 100,000 patients per year) and require immediate medical attention. If the seizure is prolonged (\> 5 minutes) it is called status epilepticus and delayed treatment leads to higher risk in drug resistance and brain injury. The current standard of care for children admitted to the ICU with established or suspected status epilepticus is to start a conventional continuous EEG study that helps diagnosing seizures by typical electro graphic patterns. It takes on average 4 hours to start and another two hours to obtain a reading by epileptologists. This is far beyond the time window of starting an EEG study (60 minutes) as recommended by the neurocritical care society. In adult ICUs, point of care "Rapid Response EEG" are becoming a new standard of care and our ICU adopted this practice in 2020. It can be easily placed by the ICU staff rather than a specifically trained EEG technician but has a lower resolution due to fewer leads (10 vs. 20). The purpose of this study is to determine wether and by how much time RR-EEG yields faster preliminary EEG reports that the previously available conventional EEG (cEEG) and wether the detection of electro graphic seizures is comparable. This is a retrospective cohort study following patients who are admitted to the PICU and are placed on either cEEG or RR-EEG for status epilepticus.
Conditions Studied
Interventions
- DEVICE Rapid Response EEG
Study Locations (1)
New York
- Children's Hospital at Montefiore - The Bronx
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2021-12-09 |
| Est. Completion | 2026-12-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06564662
The ClinicalTrials.gov registry entry for NCT06564662 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,827-participant average among 10 other Status Epilepticus trials with a reported enrollment target (98% lower). The listed sponsor is Children's Hospital at Montefiore, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Status Epilepticus appearing as the primary indexed condition, and to 1 intervention - of which Rapid Response EEG is the first listed.
NCT06564662 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT06564662 about?
NCT06564662 is a clinical study titled "Rapid-Response EEG in Children With Suspected Status Epilepticus". Seizures are common in children (\~350 per 100,000 patients per year) and require immediate medical attention. If the seizure is prolonged (\> 5 minutes) it is called status epilepticus and delayed treatment leads to higher risk in drug resistance and brain injury. The current standard of care for c...
What is the current status of trial NCT06564662?
This trial is currently recruiting. The enrollment target is 60 participants. The study started on 2021-12-09. Estimated completion is 2026-12-08.
What conditions does trial NCT06564662 study?
This clinical trial studies the following conditions: Status Epilepticus, Coma.
What interventions are being tested in trial NCT06564662?
The interventions under investigation include: Rapid Response EEG (DEVICE).
Who is sponsoring clinical trial NCT06564662?
This trial is sponsored by Children's Hospital at Montefiore, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06564662 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Status Epilepticus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Simulation Trial of Telemedical Support for Paramedics
RECRUITING · NA
-
Improving Status Epilepticus Treatment Times
RECRUITING · NA
-
PeRampanel fOr Status ePilEpticus pRophylaxis Post-cardiac Arrest
RECRUITING · Phase 2
-
Improving Outcomes for Patients With Life-Threatening Neurologic Illness
RECRUITING
-
Ketamine add-on Therapy for Established Status Epilepticus Treatment Trial (KESETT)
RECRUITING · Phase 3
-
De-identified UNMH EEG Corpus Database Creation With Fully De-identified Clinical Information
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.